IP Library › Assignment 055389/0884
Patent Assignment
Reel/Frame 055389/0884

Assignment of Assignor's Interest

Recorded: 2021-02-24 Pages: 3
Assignor
ALNYLAM EUROPE AG
Executed: 2007-06-26
Assignee
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Compositions and Methods for Inhibiting Expression of the PCSK9 Gene
Patent: 8,222,222 →
Application: 12/554,231 →
Publication: US 2011/0230542
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2021
From: TAN, PAMELA; BRAMLAGE, BIRGIT
To: ALNYLAM EUROPE AG
Reel/Frame 055389/0786 →
Assignment of Assignor's Interest Feb 24, 2021
From: FRANK-KAMENETSKY, MARIA; FITZGERALD, KEVIN; AKINC, AKIN; KOTELIANSKI, VICTOR E.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 055390/0001 →
Security Interest Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →